Bandhan Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • 1.16 %Nav, as on 09-02-2026

  • Previous Nav

  • Net Change on 09-02-2026

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 -0.31 22.00 13.94 1.82 7,875.40
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 -1.22 24.04 14.22 2.27 1,055.01
LIC MF Healthcare Fund-Regular Plan-Growth Feb 28, 2019 -5.10 19.86 10.70 2.45 78.65

Fund Holdings as on 31-January-2026

  • Sun Pharmaceutical Industries Limited

  • Apollo Hospitals Enterprise Limited

  • Divi's Laboratories Limited

  • Max Healthcare Institute Limited

  • Dr. Reddy's Laboratories Limited

  • Cipla Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Triparty Repo TRP_020226_VAL

  • Mankind Pharma Limited

  • Lupin Limited

  • Ajanta Pharma Limited

  • Dr. Lal Path Labs Limited

  • Global Health Limited

  • Aurobindo Pharma Limited

  • Glenmark Pharmaceuticals Limited

  • Syngene International Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • Rainbow Childrens Medicare Limited

  • Sai Life Sciences Limited

  • Krishna Institute Of Medical Sciences Limited

  • Abbott India Limited

  • Pfizer Limited

  • Sanofi India Limited

  • Star Health And Allied Insurance Company Limited

  • Shilpa Medicare Limited

  • Aster DM Healthcare Limited

  • Medi Assist Healthcare Services Limited

  • Jubilant Pharmova Limited

  • Onesource Specialty Pharma Limited

  • Healthcare Global Enterprises Limited

  • Concord Biotech Limited

  • Cohance Lifesciences Limited

  • Orchid Pharma Limited

  • Blue Jet Healthcare Ltd

  • Inventurus Knowledge Solutions Limited

  • Cash Margin - CCIL

  • Net Current Assets

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Business Support

  • Insurance

  • BPO/ITeS

View More

Fund Manager

  • Cash

  • Equity

View More

About Bandhan Healthcare Fund

Scheme Analysis

Bandhan Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Bandhan Mutual Fund. It was launched on 28-Nov-2025 and currently has an AUM of ₹279.60 crore. Bandhan Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index.

The NAV of Bandhan Healthcare Fund ended up ₹0.11(1.16%)yesterday to ₹9.42.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Bandhan Healthcare Fund is managed by Brijesh Shah and Viraj Kulkarni.

Fund House Contact

6th Floor, One World Centre, 841, Jupiter Mills Compound, Senapati Bapat Marg, Elphinstone Road (West), Mumbai - 400 013

022-66289999
022-24215052